OA12173A - Dual inhibitors of cholesterol ester and wax estersynthesis for sebaceous gland disorders. - Google Patents
Dual inhibitors of cholesterol ester and wax estersynthesis for sebaceous gland disorders. Download PDFInfo
- Publication number
- OA12173A OA12173A OA1200200234A OA1200200234A OA12173A OA 12173 A OA12173 A OA 12173A OA 1200200234 A OA1200200234 A OA 1200200234A OA 1200200234 A OA1200200234 A OA 1200200234A OA 12173 A OA12173 A OA 12173A
- Authority
- OA
- OAPI
- Prior art keywords
- phenyl
- acné
- diisopropyl
- acetyl
- use according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17977800P | 2000-02-02 | 2000-02-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA12173A true OA12173A (en) | 2006-05-08 |
Family
ID=22657957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200200234A OA12173A (en) | 2000-02-02 | 2001-01-23 | Dual inhibitors of cholesterol ester and wax estersynthesis for sebaceous gland disorders. |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6730703B2 (ru) |
| EP (1) | EP1263421B1 (ru) |
| JP (1) | JP2003531113A (ru) |
| KR (1) | KR20020073574A (ru) |
| CN (1) | CN1398182A (ru) |
| AP (1) | AP2002002612A0 (ru) |
| AT (1) | ATE295724T1 (ru) |
| AU (1) | AU781563B2 (ru) |
| BG (1) | BG107042A (ru) |
| BR (1) | BR0107954A (ru) |
| CA (1) | CA2398219A1 (ru) |
| CR (1) | CR6712A (ru) |
| DE (1) | DE60110897T2 (ru) |
| DZ (1) | DZ3288A1 (ru) |
| EA (1) | EA004255B1 (ru) |
| EE (1) | EE200200429A (ru) |
| ES (1) | ES2239145T3 (ru) |
| GE (1) | GEP20043286B (ru) |
| HR (1) | HRP20020717A2 (ru) |
| HU (1) | HUP0301010A3 (ru) |
| IL (1) | IL150865A0 (ru) |
| IS (1) | IS6478A (ru) |
| MA (1) | MA26872A1 (ru) |
| MX (1) | MXPA02007309A (ru) |
| NO (1) | NO20023659L (ru) |
| NZ (1) | NZ520330A (ru) |
| OA (1) | OA12173A (ru) |
| PL (1) | PL357041A1 (ru) |
| PT (1) | PT1263421E (ru) |
| SK (1) | SK10972002A3 (ru) |
| UA (1) | UA75345C2 (ru) |
| WO (1) | WO2001056556A2 (ru) |
| YU (1) | YU57502A (ru) |
| ZA (1) | ZA200206075B (ru) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1281399A3 (en) * | 2001-08-01 | 2004-02-11 | Warner-Lambert Company | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production |
| US20050031699A1 (en) | 2003-06-26 | 2005-02-10 | L'oreal | Porous particles loaded with cosmetically or pharmaceutically active compounds |
| ES2313065T3 (es) | 2003-10-09 | 2009-03-01 | Warner-Lambert Company Llc | Composiciones farmaceuticas que comprenden derivados de malonamida para disminuir la produccion de sebo. |
| AU2006217529C1 (en) | 2005-02-24 | 2013-03-07 | Medicis Pharmaceutical Corporation | Crystalline ACAT inhibitor |
| FR2904002A1 (fr) * | 2006-07-19 | 2008-01-25 | Galderma Res & Dev S N C Snc | Modulateurs de la lanosterol synthetase dans le traitement de l'acne ou de l'hyperseborrhee |
| FR2903999B1 (fr) * | 2006-07-19 | 2008-09-05 | Galderma Res & Dev S N C Snc | Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee |
| FR2938342A1 (fr) * | 2008-11-13 | 2010-05-14 | Galderma Res & Dev | Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee |
| US20100226983A1 (en) | 2009-01-28 | 2010-09-09 | Nanobio Corporation | Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof |
| BR112020025208A2 (pt) * | 2018-06-21 | 2021-03-09 | Dermavant Sciences GmbH | Formulações tópicas de inibidores de dgat1 e seus métodos de uso |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4545977A (en) * | 1985-01-11 | 1985-10-08 | G. D. Searle & Co. | Compositions and methods for treating severe acne with isotretinoin |
| US4751026A (en) | 1986-03-24 | 1988-06-14 | Warner-Lambert Company | Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase |
| US4722927A (en) | 1986-04-28 | 1988-02-02 | Warner-Lambert Company | Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase |
| EP0252524A3 (en) | 1986-07-11 | 1989-04-19 | Warner-Lambert Company | Aryl- and aralkylamide- derivatives of omega- (substituted-phenyloxy)-alkanoic acids as inhibitors of acyl-coa: cholesterol acyltransferase and pharmaceuticals containing them |
| US4716175A (en) | 1987-02-24 | 1987-12-29 | Warner-Lambert Company | Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase |
| US5015644A (en) | 1987-06-02 | 1991-05-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds |
| IE61716B1 (en) | 1987-06-02 | 1994-11-30 | Warner Lambert Co | Antihyperlipidemic and antiatherosclerotic urea compounds |
| ATE61574T1 (de) | 1987-07-02 | 1991-03-15 | Warner Lambert Co | N-((2,6-disubstituierte)-phenyl>-harnstoff und - carbamat-inhibitoren der acyl-coenzym a:cholesterol-acyltransferase. |
| US5116848A (en) | 1988-03-30 | 1992-05-26 | Warner-Lambert Company | N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents |
| US4999373A (en) | 1988-03-30 | 1991-03-12 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US4948806A (en) | 1988-03-30 | 1990-08-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US5030653A (en) | 1988-03-30 | 1991-07-09 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| US5155127A (en) | 1989-02-09 | 1992-10-13 | Warner-Lambert Company | N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents |
| US4923896A (en) | 1989-02-09 | 1990-05-08 | Warner-Lambert Company | N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents |
| US4994465A (en) | 1989-02-17 | 1991-02-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds |
| AU632809B2 (en) | 1989-05-25 | 1993-01-14 | Takeda Chemical Industries Ltd. | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof |
| AU629376B2 (en) | 1989-08-04 | 1992-10-01 | Mitsubishi Chemical Corporation | 1-phenylalkyl-3-phenylurea derivatives |
| MX22406A (es) | 1989-09-15 | 1994-01-31 | Pfizer | Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat). |
| TW205037B (ru) | 1989-10-06 | 1993-05-01 | Takeda Pharm Industry Co Ltd | |
| JPH05310678A (ja) | 1990-01-22 | 1993-11-22 | Mitsubishi Kasei Corp | １−フェニルアルキル−３−フェニル尿素誘導体 |
| US5362878A (en) | 1991-03-21 | 1994-11-08 | Pfizer Inc. | Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT) |
| ATE175196T1 (de) | 1992-01-23 | 1999-01-15 | Pfizer | 4-phenyl-3-(heteroarylureido)-1,2-dihydro-2- oxochinolin derivate, als antihypercholesterolemische und antiatherosklerotische mittel |
| KR950701621A (ko) | 1992-05-28 | 1995-04-28 | 알렌 제이. 스피겔 | 아실 조효소a : 콜레스테롤 아실 전이효소(acat)의 억제제로서 신규한 n- 아릴 및 n- 헤테로아릴우레아 유도체(new n-aryl and n-heteroarylurea derivatives as inhibitors of acyl coenzyme a : cholesterol acyl transferase(acat) |
| US5565472A (en) | 1992-12-21 | 1996-10-15 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| US5491172A (en) | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| US5596001A (en) | 1993-10-25 | 1997-01-21 | Pfizer Inc. | 4-aryl-3-(heteroarylureido)quinoline derivatves |
| US5494172A (en) * | 1994-05-12 | 1996-02-27 | Miller Compressing Company | Magnetic pulley assembly |
| US6133326A (en) * | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
| AU763687B2 (en) * | 1998-06-25 | 2003-07-31 | Tularik Inc. | Arylsulfonanilide phosphates |
| JP2004513090A (ja) * | 2000-09-27 | 2004-04-30 | メルク エンド カムパニー インコーポレーテッド | 糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体 |
-
2001
- 2001-01-23 CA CA002398219A patent/CA2398219A1/en not_active Abandoned
- 2001-01-23 CN CN01804520A patent/CN1398182A/zh active Pending
- 2001-01-23 JP JP2001556248A patent/JP2003531113A/ja active Pending
- 2001-01-23 MX MXPA02007309A patent/MXPA02007309A/es active IP Right Grant
- 2001-01-23 DZ DZ013288A patent/DZ3288A1/fr active
- 2001-01-23 PT PT01948936T patent/PT1263421E/pt unknown
- 2001-01-23 IL IL15086501A patent/IL150865A0/xx unknown
- 2001-01-23 WO PCT/US2001/002190 patent/WO2001056556A2/en active IP Right Grant
- 2001-01-23 GE GEAP20016597A patent/GEP20043286B/en unknown
- 2001-01-23 EA EA200200764A patent/EA004255B1/ru not_active IP Right Cessation
- 2001-01-23 AP APAP/P/2002/002612A patent/AP2002002612A0/en unknown
- 2001-01-23 HU HU0301010A patent/HUP0301010A3/hu unknown
- 2001-01-23 NZ NZ520330A patent/NZ520330A/en unknown
- 2001-01-23 YU YU57502A patent/YU57502A/sh unknown
- 2001-01-23 UA UA2002076160A patent/UA75345C2/uk unknown
- 2001-01-23 PL PL01357041A patent/PL357041A1/xx not_active Application Discontinuation
- 2001-01-23 EE EEP200200429A patent/EE200200429A/xx unknown
- 2001-01-23 SK SK1097-2002A patent/SK10972002A3/sk not_active Application Discontinuation
- 2001-01-23 EP EP01948936A patent/EP1263421B1/en not_active Expired - Lifetime
- 2001-01-23 DE DE60110897T patent/DE60110897T2/de not_active Expired - Fee Related
- 2001-01-23 OA OA1200200234A patent/OA12173A/en unknown
- 2001-01-23 US US10/182,847 patent/US6730703B2/en not_active Expired - Fee Related
- 2001-01-23 AU AU29718/01A patent/AU781563B2/en not_active Ceased
- 2001-01-23 BR BR0107954-9A patent/BR0107954A/pt not_active Application Discontinuation
- 2001-01-23 ES ES01948936T patent/ES2239145T3/es not_active Expired - Lifetime
- 2001-01-23 AT AT01948936T patent/ATE295724T1/de not_active IP Right Cessation
- 2001-01-23 KR KR1020027009943A patent/KR20020073574A/ko not_active Application Discontinuation
-
2002
- 2002-07-19 IS IS6478A patent/IS6478A/is unknown
- 2002-07-24 CR CR6712A patent/CR6712A/es not_active Application Discontinuation
- 2002-07-30 ZA ZA200206075A patent/ZA200206075B/en unknown
- 2002-08-01 MA MA26756A patent/MA26872A1/fr unknown
- 2002-08-01 NO NO20023659A patent/NO20023659L/no not_active Application Discontinuation
- 2002-08-29 BG BG107042A patent/BG107042A/bg unknown
- 2002-08-30 HR HR20020717A patent/HRP20020717A2/hr not_active Application Discontinuation
-
2004
- 2004-02-06 US US10/773,354 patent/US20040161393A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5716995A (en) | Anti-osteopathic composition | |
| DE3872937T2 (de) | Benzoylaminophenoxybuttersaeure-derivate. | |
| US20030134898A1 (en) | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production | |
| US3934028A (en) | Acne and psoriasis treatment with retinoic acid analogs | |
| OA12173A (en) | Dual inhibitors of cholesterol ester and wax estersynthesis for sebaceous gland disorders. | |
| CA2362343C (en) | Method and composition for treating acne | |
| US4021573A (en) | Psoriasis treatment with retinoic acid analogs | |
| LU84892A1 (fr) | Komposition zur reduktion der sebumsekretion | |
| US4007268A (en) | Process for alleviating proliferative skin diseases | |
| US4473584A (en) | Treatment of Type I Herpes virus with flurbiprofen | |
| US4701470A (en) | Treatment of Type II Herpes virus with ibuprofen | |
| US4177268A (en) | Method of alleviating inflammation by administration of dexamethasone derivatives | |
| US4477468A (en) | Treatment of type II herpes virus with flurbiprofen | |
| US3231469A (en) | beta-benzalbutyramide as an anticholesterolemic agent | |
| US3857941A (en) | Pharmaceutical compositions and use of prednisolone 17-benzoate | |
| AU604050B2 (en) | Medicament for curing neurotic disturbance or disorder comprising sialocylglycerolipid | |
| US4105794A (en) | Process of mitigating cholelithiasis | |
| CA1268124A (en) | Use of a retinoid | |
| JPS58103319A (ja) | 皮膚塗布用組成物 | |
| CN115554184A (zh) | 一种延缓薁磺酸钠氧化的方法 |